Hypermarcas (OTCMKTS:HYPMY) Sees Large Volume Increase Following Better-Than-Expected Earnings

Shares of Hypermarcas (OTCMKTS:HYPMY) saw an uptick in trading volume on Friday after the company announced better than expected quarterly earnings. Approximately 58,852 shares changed hands during trading, an increase of 165% from the previous session’s volume of 22,179 shares.The stock last traded at $4.20 and had previously closed at $4.1275.

The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on HYPMY shares. Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Hypermarcas Trading Up 1.8%

The business has a fifty day simple moving average of $4.10 and a two-hundred day simple moving average of $4.36. The company has a market cap of $2.96 billion, a PE ratio of 8.75 and a beta of 0.70.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.